Hosted by IDTechEx
Advanced Materials World
Posted on November 18, 2026 by  & 

The Expanding Universe of Biomanufactured Specialty Chemicals

From food additives and cosmetic ingredients to industrial enzymes and pigments, industrial biomanufacturing is opening new ways to produce specialty chemicals. As synthetic biology and fermentation technologies advance, these products are creating opportunities for both emerging and established chemical manufacturers.
 

 
Global market size of biomanufactured specialty chemicals will exceed US$8.5 billion by 2037. Industrial biomanufacturing uses microorganisms, enzymes, and other biological systems to produce chemicals and materials from renewable and biobased feedstocks. While much of the attention surrounding industrial biotechnology has focused on biofuels and bioplastics, significant advancement is taking place in the specialty chemicals industry. From ingredients used in everyday food and personal care products to pigments and colorants, biomanufacturing is expanding applications across an unexpectedly diverse range of markets.
 
Specialty chemicals are characterized by specialized product functionality, higher margin, and fragmented end-users. This creates opportunities for biomanufacturing companies that may not need to compete immediately with the enormous production volumes of commodity chemical manufacturers. IDTechEx's report, "Biomanufacturing Specialty Chemicals 2027-2037: Technologies, Forecasts, Markets, Players", examines this evolving landscape, covering key products, technologies, companies, and market opportunities.
 
 
A diverse product landscape
 
A vast range of specialty chemicals can be produced via biomanufacturing. Food additives represent one of the more established application areas, encompassing vitamins, amino acids, sweeteners, flavor enhancers, and hydrocolloids used to improve the texture and stability of food products. Some of these ingredients have been manufactured through industrial fermentation for decades, demonstrating that biological production is already commercially viable for selected molecules.
 
The personal care and cosmetics industry offers another important market. Ingredients such as hyaluronic acid and recombinant collagen can be produced using microbial or other engineered biological systems, offering alternatives to conventional extraction from animal or plant sources. There is also growing interest in fermentation-derived fragrances and bioactive ingredients, where the ability to produce specific molecules with consistent quality is valuable to manufacturers. Meanwhile, industrial enzymes are widely used in applications ranging from detergents and textile processing to pulp and paper manufacturing and biofuel production. Their ability to catalyze specific reactions under relatively mild conditions makes them useful tools for improving industrial process efficiency.
 
 
Specialty chemicals that can be produced via industrial biomanufacturing. Source: IDTechEx.
 
 
Why specialty chemicals could be an attractive entry point
 
The economics of specialty chemicals differ considerably from those of commodity chemicals. Commodity products such as fuels and bulk petrochemical precursors are generally produced in large volumes, with manufacturers competing heavily on production cost. Specialty chemicals, in contrast, are often valued for their specific properties, functionality, purity, or performance. This creates room for new production technologies, even when their initial costs are higher than those of established alternatives.
 
For emerging biomanufacturing companies, targeting a high-value, lower-volume application can provide a more manageable route to commercialization than competing directly in a commodity market. Biological production can also offer technical and economic advantages for molecules that are structurally complex, difficult to extract from natural sources, or challenging to synthesize through conventional chemical processes. However, this does not guarantee commercial success. Fermentation yields, downstream purification, feedstock costs, and production scale remain important determinants of competitiveness.
 
Biomanufactured pigments as an example
 
Pigments provide an interesting example of how biomanufacturing could expand the specialty chemicals landscape. Conventional synthetic pigments have long dominated the industry because of their relatively low cost, consistent performance, and established manufacturing infrastructure. However, interest in alternatives is growing, particularly in markets where manufacturers are looking to reduce reliance on petrochemicals and explore more sustainable sourcing options.
 
 
Microorganisms naturally synthesize a wide range of colored compounds, and metabolic engineering can be used to modify existing biosynthetic pathways or introduce new ones. Carotenoids, including beta-carotene, astaxanthin, and lycopene, are examples of pigments that can be produced through biological processes. Other areas of interest include microbial red pigments, blue and purple pigments, and melanin. Fermentation could offer more controlled production than plant or animal extraction, reducing exposure to seasonal variations, and addressing ethical concerns.
 
Nevertheless, biomanufacturing origin alone does not make a pigment commercially attractive. Industrial adoption depends on factors such as color intensity, stability under different processing conditions, consistency, and cost. Some biomanufactured pigments also face challenges relating to light, heat, or pH sensitivity. For biomanufacturing to gain wider market share, producers must demonstrate that their products can meet the performance requirements of downstream customers while achieving competitive production economics.
 
Outlook
 
The specialty chemicals sector illustrates how industrial biomanufacturing is moving towards a much broader portfolio of commercially relevant molecules. However, progress will not be uniform across all applications. Some established ingredients are already produced commercially, while newer molecules still face significant technical and economic barriers.
 
 
Understanding where biological production offers a genuine competitive advantage, and which companies are positioned to capture these opportunities, will be critical to assessing the industry's development. IDTechEx's report, "Biomanufacturing Specialty Chemicals 2027-2037: Technologies, Forecasts, Markets, Players", provides a detailed assessment of key specialty chemicals, examining production technologies, company activities, and market opportunities, helping stakeholders identify where biomanufacturing can deliver long-term commercial value.
 
For market intelligence on industrial biomanufacturing of commodity chemicals, see the companion IDTechEx market report: "Industrial Biomanufacturing 2027-2037: Technologies, Forecasts, Markets, Players". For more information on IDTechEx's other reports, including bioplastics and biofuels, please visit www.IDTechEx.com/Research.
 
IDTechEx guides your strategic business decisions through its Research, Subscription and Consultancy products, helping you profit from emerging technologies. For more information, contact research@IDTechEx.com or visit www.IDTechEx.com.
 

Authored By:

Technology Analyst

Posted on: November 18, 2026

More IDTechEx Journals